Malú Gámez Tansey

Malú Gámez Tansey's AcademicInfluence.com Rankings

Malú Gámez Tansey

Engineering

#6991

World Rank

#8349

Historical Rank

Biomedical Engineering

#666

World Rank

#678

Historical Rank

engineering Degrees

Download Badge

Engineering

Malú Gámez Tansey's Degrees

PhD Biomedical Engineering University of California, San Francisco
Masters Biomedical Engineering University of California, San Francisco
Bachelors Biomedical Engineering University of California, San Francisco

Why Is Malú Gámez Tansey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Malú Gámez Tansey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention (2010) (874)
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease (2008) (791)
Does neuroinflammation fan the flame in neurodegenerative diseases? (2009) (672)
Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals through the GFRα3–RET Receptor Complex (1998) (593)
Persephin, a Novel Neurotrophic Factor Related to GDNF and Neurturin (1998) (528)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention (2007) (509)
Neuroinflammation in Parkinson’s Disease (2009) (421)
TrnR2, a Novel Receptor That Mediates Neurturin and GDNF Signaling through Ret (1997) (368)
Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease (2006) (348)
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? (2017) (340)
GFRα-Mediated Localization of RET to Lipid Rafts Is Required for Effective Downstream Signaling, Differentiation, and Neuronal Survival (2000) (325)
Inhibition of Phosphatidylinositol 3-Kinase Activity Blocks Depolarization- and Insulin-like Growth Factor I-mediated Survival of Cerebellar Granule Cells* (1997) (251)
Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology (2009) (241)
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration (2008) (234)
Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. (1997) (231)
The role of innate and adaptive immunity in Parkinson's disease. (2013) (228)
Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants (2003) (221)
What does plasma CRP tell us about peripheral and central inflammation in depression? (2018) (219)
γ-Secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney (2003) (203)
Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity (2013) (201)
Microglial phenotypes in Parkinson’s disease and animal models of the disease (2017) (183)
c-Src Is Required for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Family Ligand-Mediated Neuronal Survival via a Phosphatidylinositol-3 Kinase (PI-3K)-Dependent Pathway (2001) (167)
Ca2+-dependent Phosphorylation of Myosin Light Chain Kinase Decreases the Ca2+ Sensitivity of Light Chain Phosphorylation within Smooth Muscle Cells* (1994) (161)
Myosin light chain kinase phosphorylation in tracheal smooth muscle. (1990) (160)
Inflammation and immune dysfunction in Parkinson disease (2022) (143)
Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse (2007) (138)
ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway (1996) (138)
Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells. (1992) (129)
GFRα3 is an orphan member of the GDNF/neurturin/persephin receptor family (1998) (126)
Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? (2008) (117)
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. (2008) (114)
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration (2018) (107)
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease (2020) (105)
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease (2018) (102)
Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. (2011) (100)
Microglia isolation from adult mouse brain. (2013) (97)
Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease (2008) (95)
Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B (2011) (94)
Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling (2017) (92)
Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge (2012) (90)
The TNF superfamily in 2009: new pathways, new indications, and new drugs. (2009) (88)
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice (2017) (87)
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection (2008) (86)
Regulator of G-Protein Signaling 10 Promotes Dopaminergic Neuron Survival via Regulation of the Microglial Inflammatory Response (2008) (83)
Modeling neuroinflammatory pathogenesis of Parkinson's disease. (2010) (81)
Progranulin Does Not Bind Tumor Necrosis Factor (TNF) Receptors and Is Not a Direct Regulator of TNF-Dependent Signaling or Bioactivity in Immune or Neuronal Cells (2013) (81)
Immune system responses in Parkinson's disease: Early and dynamic (2018) (80)
Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus (2021) (80)
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats. (2014) (77)
Functional Mapping of Receptor Specificity Domains of Glial Cell Line-derived Neurotrophic Factor (GDNF) Family Ligands and Production of GFRα1 RET-specific Agonists* (2000) (75)
Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease? (2012) (73)
Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice (2017) (68)
Notch1 Signaling Influences V2 Interneuron and Motor Neuron Development in the Spinal Cord (2006) (66)
Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition (2020) (65)
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes (2019) (65)
Regulator of G-Protein Signaling-10 Negatively Regulates NF-κB in Microglia and Neuroprotects Dopaminergic Neurons in Hemiparkinsonian Rats (2011) (64)
Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. (2017) (64)
TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease. (2011) (62)
LRRK2 regulation of immune-pathways and inflammatory disease (2019) (61)
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease (2008) (59)
A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets (2014) (58)
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease (2017) (58)
Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. (2012) (57)
The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins. (2015) (56)
Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons (2012) (51)
Regulation of microglia effector functions by tumor necrosis factor signaling (2012) (50)
Tumor Necrosis Factor–Neuropeptide Y Cross Talk Regulates Inflammation, Epithelial Barrier Functions, and Colonic Motility (2013) (50)
GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor family. (1998) (49)
Phosphorylation of myosin light chain kinase: a cellular mechanism for Ca2+ desensitization (1993) (47)
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation (2017) (44)
Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells (2020) (44)
Interactions Between Commensal Bacteria and Enteric Neurons, via FPR1 Induction of ROS, Increase Gastrointestinal Motility in Mice. (2019) (44)
Potential Role of the Gut Microbiome in ALS: A Systematic Review (2018) (43)
Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD (2014) (43)
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation (2020) (42)
LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s (2020) (38)
Ca 2 +-dependent Phosphorylation of Myosin Light Chain Kinase Decreases the Ca 2 + Sensitivity of Light Chain Phosphorylation within Smooth Muscle Cells (2001) (38)
Critical Role of Regulator G-Protein Signaling 10 (RGS10) in Modulating Macrophage M1/M2 Activation (2013) (37)
Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120) (2013) (37)
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36 (2020) (36)
Cytokines in CNS Inflammation and Disease (2008) (36)
Ca(2+)-dependent phosphorylation of myosin light chain kinase decreases the Ca2+ sensitivity of light chain phosphorylation within smooth muscle cells. (1994) (35)
Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice (2014) (34)
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease (2021) (32)
Chronic adolescent stress sex-specifically alters central and peripheral neuro-immune reactivity in rats (2019) (32)
RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells (2012) (31)
The Neuro-Glial Properties of Adipose-Derived Adult Stromal (ADAS) Cells Are Not Regulated by Notch 1 and Are Not Derived from Neural Crest Lineage (2008) (28)
α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis (2018) (28)
Myosin phosphorylation in smooth and skeletal muscles: regulation and function. (1990) (28)
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease (2020) (27)
RNF11 modulates microglia activation through NF-κB signalling cascade (2012) (27)
Spinal Motor Circuit Synaptic Plasticity after Peripheral Nerve Injury Depends on Microglia Activation and a CCR2 Mechanism (2019) (26)
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis (2018) (26)
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series (2020) (23)
RGS10 Negatively Regulates Platelet Activation and Thrombogenesis (2016) (23)
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease? (2021) (22)
Isolation of murine postnatal brain microglia for phenotypic characterization using magnetic cell separation technology. (2013) (21)
Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1−/− mice (2013) (19)
Nomenclature of GPI-Linked Receptors for the GDNF Ligand Family (1997) (19)
Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls (2021) (19)
Model Organisms in Spinal Cord Regeneration (2008) (18)
Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology (2021) (18)
Myosin light chain kinase phosphorylation: regulation of the Ca2+ sensitivity of contractile elements. (1991) (18)
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis (2016) (18)
Physiology of RGS10 in Neurons and Immune Cells. (2015) (17)
Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial. (2017) (16)
Age-related changes in regulator of G-protein signaling (RGS)-10 expression in peripheral and central immune cells may influence the risk for age-related degeneration (2015) (15)
Adolescent stress sensitizes the adult neuroimmune transcriptome and leads to sex-specific microglial and behavioral phenotypes (2021) (15)
The duality of TNF signaling outcomes in the brain: Potential mechanisms? (2011) (14)
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis (2022) (13)
Inflammation in neuropsychiatric disease (2010) (12)
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms (2022) (11)
The Role of Neuroinflammation in Parkinson's Disease (2011) (11)
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease (2020) (11)
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration (2018) (11)
The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence (2020) (10)
Chronic psychological stress during adolescence induces sex-dependent adulthood inflammation, increased adiposity, and abnormal behaviors that are ameliorated by selective inhibition of soluble tumor necrosis factor with XPro1595 (2019) (10)
Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: implications for disease-dependent drug–drug interactions (2014) (9)
AAV-Dominant Negative Tumor Necrosis Factor (DN-TNF) Gene Transfer to the Striatum Does Not Rescue Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease (2014) (9)
Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors (2016) (9)
A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL (2019) (9)
Poldip2 controls leukocyte infiltration into the ischemic brain by regulating focal adhesion kinase-mediated VCAM-1 induction (2021) (7)
Alternatives to amyloid for Alzheimer's disease therapies—a symposium report (2020) (7)
Parkinsonism without dopamine neuron degeneration in aged l‐dopa‐responsive dystonia knockin mice (2017) (6)
Linking mitochondria to the immune response (2020) (6)
Challenges in Passive Immunization Strategies to Treat Parkinson Disease. (2018) (5)
Inflammation-Related Factors Identified as Biomarkers of Dehydration and Subsequent Acute Kidney Injury in Agricultural Workers (2021) (5)
Inflammation in Neurodegenerative Disease and Injury (2009) (5)
The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss (2019) (5)
WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes (2022) (5)
RGS 10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis (4)
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation (2017) (4)
Regulation of Myosin Light Chain Kinase Activity in Smooth Muscle (1995) (4)
TNFα increases tyrosine hydroxylase expression in human monocytes (2021) (3)
Editorial Board (2018) (3)
Editorial Board (2018) (3)
Infection triggers symptoms similar to those of Parkinson’s disease in mice lacking PINK1 protein (2019) (3)
Neuroin fl ammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer ’ s disease (2008) (3)
TNFα increases tyrosine hydroxylase expression in human monocytes (2021) (3)
Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease (2020) (3)
ELEVATED CENTRAL AND PERIPHERAL INFLAMMATORY PROFILES IN A POPULATION AT RISK FOR ALZHEIMER’S DISEASE (2017) (3)
142nd Annual Meeting of the American Neurological Association (1978) (3)
Publisher Correction: Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus (2021) (2)
Role of the Innate and Adaptive Immune System in the Pathogenesis of PD (2014) (2)
Inflammation in nervous system disorders (2015) (2)
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium (2022) (2)
Neuroinflammation in Age-Related Neurodegenerative Diseases (2018) (2)
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial (2022) (2)
Alzheimer’s disease research progress in Australia: The Alzheimer’s Association International Conference Satellite Symposium in Sydney (2021) (2)
Editorial for Special issue on Microbiome in neurological and psychiatric disease (2019) (2)
Sexually dimorphic responses to MPTP found in microglia, inflammation and gut microbiota in a progressive monkey model of Parkinson’s disease (2020) (1)
Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons (2012) (1)
GFR a 3 is an orphan member of the GDNF y neurturin y persephin receptor family (1998) (1)
Inhibition of soluble TNF protects mice against brain inflammation and demyelination in a cuprizone model for multiple sclerosis (2014) (1)
Inflammatory profiles, gut microbiome, and kidney function are impacted after high-fidelity firefighter training. (2022) (1)
Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system (2022) (1)
WESTERN DIET PROMOTES CENTRAL INSULIN IMPAIRMENT AND THE DYSREGULATION OF METABOLITES ASSOCIATED WITH ALZHEIMER’S DISEASE: THE ROLE OF SOLUBLE TNF (2019) (1)
RGS10 Mediates Changes in Gut Permeability and Inflammation After an Intestinal Inflammatory Challenge (2017) (1)
Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1−/− mice (2013) (1)
The complex role of inflammation and gliotransmitters in Parkinson's disease (2022) (1)
ELUCIDATING THE RELATIONSHIP BETWEEN HYPERPHOSPHORYLATED TAU AND LOCUS COERULEUS DEGENERATION IN ALZHEIMER’S DISEASE (2016) (0)
27. Neuroinflammation mediates the delayed behavioral effects of microembolism (2014) (0)
Editorial Board (2018) (0)
The role of TNF in in vitro and in vivo models of neurodegeneration (2006) (0)
Peripheral administration of the novel tnf inhibitor xpro1595 improves synaptic function in the 5XFAD model of Alzheimer's disease (2015) (0)
P-196 YI TNF-α Inhibitors Attenuate Neuropeptide Y (NPY) Expression in the Murine Enteric Nervous System: Implications in Inflammation and Colonic Motility (2012) (0)
Editorial Board (2018) (0)
Regulator of G Protein Signaling 10 is a novel regulator of intestinal inflammation (2016) (0)
Editorial Board (2018) (0)
Editorial Board (2018) (0)
Workshop summary: roles of the TNF family in neuronal development, function and pathology. (2011) (0)
Soluble TNF mediates amyloid-independent, diet-induced alterations to immune and neuronal functions in an Alzheimer’s disease mouse model (2023) (0)
Editorial Board (2017) (0)
Effect of High Fat High Fructose Diet on Peripheral Immune Cell Trafficking into the Brain in CCR2 Mouse Model (2018) (0)
Editorial Board (2017) (0)
Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology (2021) (0)
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease? (2021) (0)
Editorial Board (2017) (0)
328: DEPENDENCY OF CARDIAC OUTPUT ON SUBSTRATE SUPPLY IN MUSCLE GLYCOGEN STORAGE DISEASES (1987) (0)
Review for "Role of Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neurodegenerative Dementias" (2020) (0)
APOE and immunity: Research highlights. (2023) (0)
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration (2018) (0)
Editorial Board (2018) (0)
Editorial Board (2018) (0)
A novel function of RGS10 in effector T lymphocytes to augment mouse EAE (BA8P.126) (2014) (0)
Tu2103 TNF-α Inhibitors Modulate Colonic Motility in Murine Experimental Colitis (2013) (0)
Regulator of G‐protein signaling (RGS10) regulates microglial response to chronic inflammatory stimuli and impacts dopaminergic neuron survival. (2008) (0)
Heat-Intensive Firefighter Training Induces Altered Inflammatory Profiles and Microbiota Composition and Potential Acute Kidney Injury (2022) (0)
Editorial Board (2018) (0)
Soluble TNF mediates high‐fat and high‐carbohydrate diet–induced inflammation, alterations in peripheral blood and brain immunophenotype, and gut microbiome in a mouse model of amyloid pathology (2020) (0)
The role of cannabinoid receptor 2 in microglial clearance of human tau (2021) (0)
Modeling microglia to explore the immune component of neurodegenerative disease (2018) (0)
PERIPHERAL AND CENTRAL INFLAMMATION ASSOCIATE WITH PHOSPHO-TAU IN A POPULATION AT RISK FOR ALZHEIMER’S DISEASE (2019) (0)
Interleukin‐6 Induced Differential Gene Expression in mDCT15 Cells (2020) (0)
Interleukin‐6 Mediated Regulation of ENaC via Time‐Dependent MAPK Family Activation (2021) (0)
Spreading of Tau and other corrupted proteins through the gut‐brain axis (2022) (0)
Pesticide-induced Immunotoxicity May Underlie Synergistic Gene-environment Interactions that Increase Parkinson's Disease Risk for High-risk Genotype Individuals at rs3129882 in the HLA-DRA Gene (2016) (0)
The role of soluble TNF in mediating immune and metabolic alterations in a mouse model of amyloid‐beta pathology (2021) (0)
Lactobacilli ‐induced Generation of Reactive Oxygen Species via Formyl Peptide Receptor‐1 (FPR1) Regulates Intestinal Motility in Mice (2019) (0)
Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells (2022) (0)
Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: a potential new treatment route for amyotrophic lateral sclerosis (2022) (0)
PHASE 1B OPEN-LABEL, BIOMARKER-DIRECTED STUDY OF THE BRAIN PENETRANT, SOLUBLE SELECTIVE INHIBITOR OF SOLUBLE TUMOR NECROSIS FACTOR XPRO1595 IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE (2019) (0)
Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice (2022) (0)
Editorial Board (2017) (0)
Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge (2012) (0)
Poldip2 controls leukocyte infiltration into the ischemic brain by regulating focal adhesion kinase-mediated VCAM-1 induction (2021) (0)
Editorial Board (2017) (0)
Editorial Board (2018) (0)
Editorial Board (2018) (0)
TNF‐&agr; Inhibitors Attenuate Neuropeptide Y (NPY) Expression in the Murine Enteric Nervous System: Implications in Inflammation and Colonic Motility: P‐196 YI (2012) (0)
RNA-SEQ REVEALS HSP90 AS A REGULATOR FOR INTERLEUKIN 6-MEDIATED ACTIVATION OF NCC VIA THE MINERALOCORTICOID RECEPTOR (2021) (0)
Editorial Board (2017) (0)
P3-265 In vivo and in vitro validation of TNF as a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of PD and AD (2006) (0)
P3.050 Role of tumor necrosis factor in the progressive phase of dopaminergic neuron death in a rat model of Parkinson's disease (2009) (0)
Loss of progranulin leads to dysregulation of innate and adaptive immune cell populations, increased susceptibility to experimental colitis, and brain infiltration of peripheral immune cells (2020) (0)
ROLE OF SOLUBLE TNF IN DIET-INDUCED PERIPHERAL AND CENTRAL INFLAMMATION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE (2017) (0)
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration (2018) (0)
Additional file 8: of Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease (2017) (0)
Synaptoprotective effects of the novel TNF inhibitor XPRO1595 in 5xFAD mice: Interactions between Western diet and sex (2020) (0)
Editorial Board (2018) (0)
THE ROLE OF SOLUBLE TNF IN METABOLIC DYSFUNCTION AND BBB ALTERATIONS IN A MOUSE MODEL OF ALZHEIMER’S DISEASE (2018) (0)
The Alzheimer’s risk gene APOE modulates the gut–brain axis (2023) (0)
Top‐line data from a phase 1b biomarker‐directed, proof of biology study in Alzheimer's patients treated with XPRO1595, a second‐generation treatment for immune dysfunction (2020) (0)
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? (2017) (0)
Additional file 9: of Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease (2017) (0)
Genetic and environmental factors in Parkinson’s converge on immune function and inflammation (2021) (0)
Editorial Board (2017) (0)
Editorial Board (2011) (0)
Microbiome influences on neuro-immune interactions in neurodegenerative disease. (2022) (0)
RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis (2016) (0)
Editorial Board (2017) (0)
Do microglial glucocorticoid receptors protect against loss of dopaminergic neurons in Parkinson's disease? (2011) (0)
Molecular signatures of neuroinflammation induced by α‐synuclein aggregates in microglial cells (2020) (0)
Editorial Board (2017) (0)
Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes (2021) (0)
Modulation of peripheral immune cell traffic to the CNS by XPro1595 in a mouse model of Alzheimer's disease (2013) (0)
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease (2017) (0)
SOLUBLE TNF MEDIATES HIGH-FAT-HIGH-CARBOHYDRATE DIET–INDUCED ALTERATIONS IN PERIPHERAL AND BRAIN IMMUNOPHENOTYPE IN A MOUSE MODEL OF ALZHEIMER’S DISEASE (2019) (0)
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis (2022) (0)
Editorial Board (2017) (0)
PERIPHERAL AND CENTRAL INFLAMMATION DIFFER BY RACE AND ASSOCIATE WITH COGNITIVE PERFORMANCE IN A POPULATION AT RISK FOR ALZHEIMER’S DISEASE (2019) (0)
Editorial Board (2017) (0)
TARGETING CANNABINOID TYPE 2 RECEPTORS TO MODULATE INFLAMMATION AND PROTECT AGAINST ASYN-INDUCED PD-LIKE PATHOLOGIES (2018) (0)
Renal‐Specific Dendritic Cell Depletion Reduces Urinary Interleukin 6 Levels Following Angiotensin II‐Mediated Hypertension and Dietary High Salt (2017) (0)
Assessing stimulation‐dependent changes in LRRK2 and GCase expression/activity and convergence at the lysosome in cryopreserved monocytes (2021) (0)
Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes (2021) (0)
The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy (2017) (0)
PROGRANULIN LOSS DYSREGULATES SPLENIC AND PERIPHERAL BLOOD IMMUNE CELL POPULATIONS AND MAY CONTRIBUTE TO NEUROINFLAMMATION AND NEURODEGENERATION IN FRONTOTEMPORAL DEMENTIA (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Malú Gámez Tansey?

Malú Gámez Tansey is affiliated with the following schools:

Washington University in St. Louis
Emory University
University of Florida
University of Miami
University of California, San Francisco
University of Florida College of Medicine
University of Texas Southwestern Medical Center